Hostname: page-component-76fb5796d-vfjqv Total loading time: 0 Render date: 2024-04-25T21:27:33.823Z Has data issue: false hasContentIssue false

Conclusion of Avery et al—Validation of Findings But Concern about Rationale

Published online by Cambridge University Press:  02 January 2015

Rebekah W. Moehring*
Affiliation:
Department of Medicine, Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina
Daniel J. Sexton
Affiliation:
Department of Medicine, Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina
Deverick J. Anderson
Affiliation:
Department of Medicine, Division of Infectious Diseases, Duke University Medical Center, Durham, North Carolina
*
PO Box 102359, Department of Medicine, Division of Infectious Diseases, Duke University Medical Center, Durham, NC 27710 (rebekah.moehring@duke.edu)
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2012

References

1.Avery, TR, Kleinman, KP, Klompas, M, Aschengrau, A, Huang, SS. Inclusion of 30-day postdischarge detection triples the incidence of hospital-onset methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2012;33(2): 114121.CrossRefGoogle ScholarPubMed
2.Cohen, AL, Calfee, D, Fridkin, SK, et al. Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA/HICPAC position paper. Infect Control Hosp Epidemiol 2008;29(10): 901913.CrossRefGoogle ScholarPubMed
3.Klevens, RM, Morrison, MA, Nadle, J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007;298(15): 17631771.CrossRefGoogle ScholarPubMed